Skip to main content
Caplight Logo









Fapon Biotech

Fapon Biotech

Private
DongguanHealthcare & Life Scienceshttps://www.faponbiotech.com/

Last Round

IPO

Feb 22, 2024

Est. Valuation

$3.48B

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Fapon Biotech is a life sciences company that provides integrated solutions and services for diagnostics, biopharma, and biotherapy, including raw materials, reagents, and open instrument platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

in-vitro diagnosticsIVDIVD raw materialschemiluminescence immunoassayCLIA analyzersopen-system instrumentsdiagnostic reagentsone-stop IVD solutiondiagnostic instrumentstherapeutic antibodiesAI-powered protein designAI drug discoveryprotein engineeringmulti-omics platformcircular RNA therapyveterinary diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fapon Biotech Comparables

Compare Fapon Biotech with similar companies based on industry and business-model similarity.

Fapon Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SD Biosensor Inc
82%
Medix Biochemica
79%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
78%

Fapon Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 22, 2024
Series BDec 30, 2020
Early FundingJan 1, 2019
Private PlacementMay 10, 2017
Private PlacementAug 1, 2016

Key People

Founding team and executive leadership

Paul Lundquist

Chief Technology Officer, Sequencing

Executive Team

Fapon Biotech Investors

Notable investors and investment history

Fapon Biotech investors
InvestorRounds
Cathay CapitalSeries B
GL Capital GroupSeries B
Dingfeng Asset ManagementPrivate Placement
明道投资Private Placement
Huatai United SecuritiesIPO
Share CapitalSeries B
HongShan Capital Group (HSG)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 231% MoM.

  • Jun 21, 2026

    Monthly visitors increased 532% MoM.

Fapon Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fapon Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fapon Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDongguan
Employee Range181
Year Founded2001
Last FundingFeb 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?